Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway. - Wikidata - awgldk - TriplyDB

Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway.

Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway.

http://www.wikidata.org/entity/Q33756664

about

Early injury of the neonatal lung contributes to premature lung aging: a hypothesis Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia Analysis of the transcriptome in hyperoxic lung injury and sex-specific alterations in gene expression.Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung.Deferoxamine Improves Alveolar and Pulmonary Vascular Development by Upregulating Hypoxia-inducible Factor-1α in a Rat Model of Bronchopulmonary Dysplasia.Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia.Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension.Altered lung development in bronchopulmonary dysplasia.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.A review of recent developments and applications of morphometry/stereology in lung research.Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia.Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.Inhibition of Regulatory-Associated Protein of Mechanistic Target of Rapamycin Prevents Hyperoxia-Induced Lung Injury by Enhancing Autophagy and Reducing Apoptosis in Neonatal Mice.Maternal molecular hydrogen treatment attenuates lipopolysaccharide-induced rat fetal lung injury.Looking ahead: where to next for animal models of bronchopulmonary dysplasia?Diagnosis and treatment of pulmonary hypertension in infancy.Beyond pulmonary hypertension: sildenafil for chronic lung disease of prematurity.Improved pulmonary function in the nitrofen model of congenital diaphragmatic hernia following prenatal maternal dexamethasone and/or sildenafil.Functional assessment of hyperoxia-induced lung injury after preterm birth in the rabbit.Effects of Hyperoxia on the Developing Airway and Pulmonary Vasculature.Why vessels do matter in pulmonary disease.Cardiac natriuretic peptides promote adipose 'browning' through mTOR complex-1.

P2860

Q26741052-431594EB-1E16-44EF-80F7-0D9E6F97091D Q26744473-3FCA5435-6D40-4A22-94F3-25BA06ACABCB Q26750310-E918C2E0-D549-4F99-8F8E-E2F14D174A34 Q33622213-A42EE879-89B4-482D-9D7E-C0E916F1F67D Q33863629-A42378FD-DEAF-4F6A-B90B-C73921F106FD Q34669226-61619390-F40B-4944-AB4D-BB6A51F0A233 Q35016361-7A4AF035-5DB3-4626-BCE6-62089A2F2F6D Q36007854-386A8FB6-B7B9-41CC-BF5C-539B9D47DDD3 Q36103389-A3061607-D068-4C2C-A30E-909DF0B1EDD8 Q36382353-64830854-FB38-410F-AE82-15AD4B535BFA Q36730928-8FE16342-FE4F-4053-B461-F796444D910D Q37418778-D4D58EBD-5F7C-4F6B-8B53-57FFABE2DA97 Q37596144-AB02DF61-9BC2-491D-AC00-D466EBEDCA72 Q38196734-947465BF-368D-421F-B3C7-3608ABB3489D Q38271628-0844D02B-7459-429F-8436-18877F50BBDA Q38549538-C92FBE4B-7EF7-4CB1-B464-93AC5D5DBADD Q38585146-B2080371-81CD-4BBD-81E3-1F1AB6409A7C Q38632257-EC82A7A8-D8CC-4F1D-A8D1-93DE2286D242 Q38735257-5F354468-5368-40D6-9E69-AB4DE4F60AFA Q38878382-F7FA226A-CEAF-4BD1-9345-141D50D076A1 Q39029148-BD4E5E9A-CE67-4560-B3CB-356C42852C50 Q42508912-4E8DBD56-E998-484F-BCF2-0D6CC59EE758 Q44062958-54109350-D2C3-4614-8687-238BDDDC3EF3 Q46307865-C5C496A9-A323-4B1F-86B2-BA97C537D46F Q46337050-AFB9098B-732F-4444-A0FD-F847E1691C06 Q47431365-0DF60141-0E84-4A09-A767-7825C9BBA83F Q48664496-98D2FEA3-0D74-4F9F-83F1-B579F6A7C588 Q49358959-0546C10C-D277-4623-BD39-875D69FCFABA

P2860

Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway.

http://www.wikidata.org/entity/Q33756664

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@ast

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@en

type

label

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@ast

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@en

prefLabel

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@ast

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@en

P1433

Q33756664-6E6DB3D7-8DD7-4A70-A45A-8E6F2CE198AA

P1476

Q33756664-70375CF2-891E-4607-B78A-E817A0DD894E

P2093

Q33756664-2469D647-1BB1-4C74-8738-CCA2840C73AD

Q33756664-86DDC5A0-4C06-4693-A8C2-069C180C306A

Q33756664-94135A47-1AB5-40DE-8C03-B7A1D9378CBC

Q33756664-A05FF94A-41CE-48D3-BEFC-29276A27CC16

Q33756664-A7038658-D7E4-4191-88F9-B80C090AD70A

Q33756664-AA233BA8-5732-4993-B7A1-E0B77F6AA289

Q33756664-EE93F525-7B28-4DC2-8BAF-F0EAA9F4CFE2

P2860

Q33756664-159F5E29-302A-468D-8EC5-3FABE891B8F8

Q33756664-1E69B9B5-56FA-4A46-80E7-F4756ECFEFF9

Q33756664-251618A3-C32F-4C93-9BB3-380DCBF1AC8E

Q33756664-29BBC97A-51AE-423E-A326-47D2083D6BFF

Q33756664-2B6624D6-57F2-442E-8DAF-49A19D4C605F

Q33756664-2F9FABB3-5725-43B4-A055-3A175B06653B

Q33756664-30B86D95-7BC5-4861-9AA9-9EC3A35F896A

Q33756664-3350D3D3-1894-4C6C-A9B8-ACD88040C467

Q33756664-360ED5EF-9083-4462-AA85-37531682E491

Q33756664-4C484721-1C1E-4F7D-A2EB-6FC87D3817DC

P304

Q33756664-8B364148-DB8C-4F74-89D7-76548075871E

P31

Q33756664-C6A30909-268E-4117-BADE-B721E2F59C2C

P356

Q33756664-E39E790B-7AE9-413E-A8BB-A71A397DD804

P433

Q33756664-9BF53797-C6C9-49FD-B6B0-63528C3FA536

P478

Q33756664-4C7C12F1-B39D-4161-97C9-63A9D0D4E8CB

P577

Q33756664-F4DA914D-26ED-4037-97CF-9C467ACE8D14

P698

Q33756664-DFE7FF3B-5A39-48E4-987D-0291ADC5A53C

P921

Q33756664-9738A217-8D4B-4D08-ABE2-8D5353EFBA26

Q33756664-9B4E44DF-4553-4619-B1A5-0CC7376BA819

P932

Q33756664-35D2D05E-5D43-4B71-8140-293A108B02DB

P356

RCMB.2012-0043OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Sildenafil alleviates bronchop ...... ible factor signaling pathway.

@en

P2093

Byung Il Kim

http://www.w3.org/2001/XMLSchema#string

Chang Won Choi

http://www.w3.org/2001/XMLSchema#string

Hye-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Hyoung-Sook Park

http://www.w3.org/2001/XMLSchema#string

Hyun-Ju Lee

http://www.w3.org/2001/XMLSchema#string

Jong-Wan Park

http://www.w3.org/2001/XMLSchema#string

Yang-Sook Chun

http://www.w3.org/2001/XMLSchema#string

P2860

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation

Antenatal infection/inflammation and postnatal lung maturation and injury

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds

Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization

Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes.

Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms.

The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.

P304

105-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2012-0043OC

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23065129

http://www.w3.org/2001/XMLSchema#string

P921

bronchopulmonary dysplasia

P932

5455467

http://www.w3.org/2001/XMLSchema#string